ESC Professional Premium Access

The effect of P2Y12 inhibitor monotherapy according to bleeding risk: a systematic review and meta-analysis

Congress Presentation

About the speaker

Ms Eva Christine Ida Woelders

Radboud University Medical Centre, Nijmegen (Netherlands (The))
0 follower

5 more presentations in this session

Patient knowledge about risk factors, achievement of target values and guideline adherent secondary prevention 12 months after acute myocardial infarction. Results of the prospective GULLIVE-R study.

Speaker: Professor U. Zeymer (Ludwigshafen, DE)


Infarct size, inflammatory burden and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry.

Speaker: Doctor A. Sansonetti (Bologna, IT)


Positive predictive value of the crusade score for bleeding events in patients with acute coronary syndromes on dual antiplatelet therapy with acetylsalicylic acid and clopidogrel

Speaker: Doctor J. Monteiro (Vila Real, PT)


To pretreat or not no pretreat with dual antiplatelet therapy in non-ST elevation acute coronary syndrome patients: that is the question.

Speaker: Doctor D. Abella Vallina (Burgos, ES)


Effect of alirocumab added to high-Intensity statin therapy on endothelial function in patients with acute myocardial infarction: A sub-study of the randomized placebo-controlled PACMAN-AMI trial

Speaker: Doctor E. Rexhaj (Bern, CH)


Access the full session

Treatment of coronary artery disease

Speakers: Ms E. Woelders, Professor U. Zeymer, Doctor A. Sansonetti, Doctor J. Monteiro, Doctor D. Abella Vallina...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb